JointMetrix Medical Presents Novel Joint Monitoring Technology

Company is Pioneering use of Remote Monitoring in Orthopaedics

Jan 28, 2013, 14:28 ET from JointMetrix Medical

SEATTLE, Jan. 28, 2013 /PRNewswire/ -- JointMetrix Medical has developed novel remote monitoring technology for use in conjunction with joint replacement surgery.  An abstract describing use of the system was presented today at the 2013 Meeting of the Orthopaedic Research Society in San Antonio, TX.

The system was developed by JointMetrix Medical in collaboration with a team of clinicians and researchers at University of Washington's Department of Orthopaedics and Sports Medicine.  Several leading US Orthopaedic centers are preparing research initiatives that leverage the system, which is expected to be commercially released later in 2013.

JointMetrix Medical's remote monitoring technology enables continuous and accurate measurement of patients' joint motion and overall activity, providing a breakthrough in clinicians' ability to track and positively influence post-surgical outcomes.

"Remote monitoring will be an important element of care in Orthopaedics, allowing clinicians to more appropriately select and care for their patients," said Dave Marver, CEO, JointMetrix Medical. "The data our system provides will allow earlier and more effective intervention while providing much needed efficiencies for busy surgeons and their staffs."

About JointMetrix Medical

JointMetrix Medical, LLC was created to commercialize technology developed by Peter Cavanagh, Ph.D., D.Sc., former Chairman of Biomedical Engineering at Cleveland Clinic and current Vice Chair for Research in the Department of Orthopaedics and Sports Medicine at University of Washington. Dr. Cavanagh developed JointMetrix Medical's underlying technology over the last decade in connection with NASA-sponsored research to measure astronauts' activity aboard the International Space Station. The company is pioneering clinical use of remote monitoring in Orthopaedics. Its first product, a system intended for use in conjunction with total knee arthroplasty, is expected to be commercially released in the US in 2013.




SOURCE JointMetrix Medical